Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Oklahoma-based financial advisors John “David” Veitch and his son Drew are joining Raymond James’ employee advisor channel, ...

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

RBC Capital Mkts has recently initiated Jumia Technologies AG – ADR (JMIA) stock to Sector Perform rating, as announced on November 13, 2024, according to Finviz. Earlier, on July 9, 2024, The ...

The Nifty 50 index has now re-entered correction territory – a 10% fall – since its most recent high in late September.

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...

Magnificent Seven performed strongly last year, but how will they fare in 2025? Explore experts’ tech stock predictions for ...

Terence Flynn, Biotech Analyst at Morgan Stanley, discusses Eli Lilly's recent stock boost and its designation as Morgan Stanley's top pick for 2025. He highlights the robust growth potential of Eli ...

Two Morgan Stanley analysts have outlined bull-case target prices that imply substantial upside for Datadog and Arm ...

Morgan Stanleys Chief US Equity Strategist, Mike Wilson, forecasts a volatile first half of 2025, with recovery prospects ...

Reliance Industries' stock valuation hits a 3-year low, offering a strong risk-reward opportunity. Analysts foresee growth in ...

Morgan Stanley closed $8.38 short of its 52-week high ($136.24), which the company achieved on November 25th.